2 - Correlation and Assessment of Small Bowel Lesions Using Cross-Sectional Imaging Techniques vs Small Intestinal Contrast UltraSonography in Known Crohn’s Disease (CACTUS-CD Trial): A Paired, Validating Study (NCT06125678)
3 - Insurance Coverage for Endoscopic Bariatric Therapy in 2024: Analyses of the Top Insurers in the U.S.
Location: Terrace Ballroom
Presenting Author: Sagar Shah, MD – David Geffen School of Medicine at UCLA
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 28th
8:36 AM - 8:48 AM ET
4 - Heartburn Frequency and Symptom Improvement Rates of Treated Episodes when Switching From Daily to On-Demand Vonoprazan Treatment for Non-Erosive Reflux Disease
6 - Efficacy, Safety, and Tolerability of MoviPrep vs GoLYTELY for Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy: A Randomized Controlled Trial
7 - Comparative Effectiveness of Biofeedback and Dextranomer/Hyaluronate Injection for Treatment of Fecal Incontinence: A Multicenter Randomized Controlled Trial
8 - Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Propensity-Matched Cohort Study
9 - Rifaximin Monotherapy Is More Effective Than Lactulose Monotherapy for Reducing the Risk of Overt Hepatic Encephalopathy (OHE) Recurrence and All-Cause Mortality: An Analysis of Two Randomized Trials
10 - Comparative Outcomes Based on the Duration of Vasoconstrictors After Endoscopic Variceal Ligation in Acute Variceal Bleeding: A Systematic Review and Network Meta-Analysis of Randomized Studies
11 - Evolving Burden of Colorectal Cancer and its Attributable Risk Factors and its Trend from 1990-2021: Insights from the Global Burden of Disease Study 2021
Location: Terrace Ballroom 1
Presenting Author: Bhargav Koyani, MD – Saint Francis Hospital, Evanston
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 28th
2:15 PM - 2:25 PM ET
15 - Efficacy and Cost Savings With Diclofenac Suppository for Post-ERCP Pancreatitis: Experience From a Tertiary Care Center
Location: Terrace Ballroom 2-3
Presenting Author: Robin Wilson, MD – University of Rochester Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 28th
2:25 PM - 2:35 PM ET
12 - Artificial Intelligence-Assisted Colonoscopy Is Associated With Higher Conversions From Screening to Therapeutic Exams
19 - Phase 3, Double-Blind, Randomized STARS Trial of Apraglutide Once-Weekly in Patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF): Subgroup Analyses by Baseline Demographics and SBS Disease Characteristics
30 - Risk of Bleeding After Colorectal Endoscopic Mucosal Resection in Patients With Cirrhosis: A Propensity-Matched Analysis of the US Collaborative Network
Location: Terrace Ballroom 2-3
Presenting Author: Azizullah Beran, MD – Indiana University School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 29th
9:00 AM - 9:10 AM ET
22 - The Use of Non-Fasting Breath Gas Levels to Predict Response to a FODMAP Restricted Diet
31 - Think Before You Ink: Endoscopist-Rated Utility of Tattoo Placement for Identifying Colorectal Polyps Referred for Endoscopic Resection – A Prospective Multicenter Study
34 - Gastrointestinal Bleeding in Post-PCI Patients on Antiplatelet Therapy and the Predictive Value of the PRECISE-DAPT Score
Location: Terrace Ballroom 2-3
Presenting Author: Jesus Guzman, MD – Division of Gastroenterology, Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 29th
9:40 AM - 9:50 AM ET
26 - Impact of Sex on Liver Transplant Waitlist and Post-Transplant Outcome by Disease Etiology
46 - Comparative Efficacy and Safety of Bariatric Surgery, Bariatric Endoscopy, and GLP-1 Receptor Agonists in Obesity Management: A Network Meta-Analysis
47 - Durability and Weight Outcomes of the Bariatric Anastomotic Reduction System Clips in Patients With Refractory Weight Regain After (RYGB) Gastric Bypass Surgery: A 1-Year Follow-Up Study
49 - Artificial Intelligence-Assisted Digital Cholangioscopy for the Diagnosis and Morphological Characterization of Indeterminate Biliary Strictures: A Multicentric Study
41 - Efficacy of 10-day VAL (Vonoprazan, Amoxicillin, and Levofloxacin) vs 14-day Standard Triple Therapy for Helicobacter pylori Eradication A Multicenter Randomized Controlled Trial
42 - Evaluating the Use of an On-Demand Telehealth Platform as a Mechanism to Prevent Emergency Department (ED) Visits for Patients Presenting With Gastrointestinal (GI) Symptoms
51 - Safety and Efficacy of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Branch Duct-Intraductal Papillary Mucinous Neoplasms: A Single Arm Clinical Trial
Location: Terrace Ballroom 2-3
Presenting Author: Vanisha Patel, MD – The Ohio State University Wexner Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 29th
3:15 PM - 3:25 PM ET
43 - Cendakimab Efficacy and Safety in Adult and Adolescent Patients With Eosinophilic Esophagitis 48-Week Results From the Randomized, Placebo-Controlled, Phase 3 Study (Late-Breaking Abstract)
44 - Efficacy, Safety and Immunogenicity of Subcutaneous Infliximab (CT-P13 SC) Monotherapy versus Combination Therapy With Immunosuppressants Post hoc Analysis of LIBERTY-CD and LIBERTY-UC Studies (Late-Breaking Abstract)
53 - Development and Validation of a Mortality Risk Score for Acute Pancreatitis Patients in the ICU
Location: Terrace Ballroom 2-3
Presenting Author: Hassam Ali, MD – East Carolina University Brody School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 29th
3:35 PM - 3:45 PM ET
45 - Impact of Elafibranor on Markers of Disease Activity and Progression in Patients With Advanced Primary Biliary Cholangitis (Late-Breaking Abstract)
54 - Identifying Diagnostic Patterns for Exocrine Pancreatic Insufficiency in Adults With Chronic or Recurrent Acute Pancreatitis: Findings From the PACT-CP Registry
65 - Fecal Microbiota Transplantation (FMT) With Bezlotoxumab Was Not Better Than FMT Alone in Inflammatory Bowel Disease Patients and Recurrent Clostridioides difficile Infection Results from a Randomized Controlled Trial
56 - Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis and Compensated Liver Cirrhosis in the Open-Label, Long-Term ASSURE Safety Study: Interim Results
Location: Terrace Ballroom 1
Presenting Author: Stuart Gordon, MD – Creighton University School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
8:40 AM - 8:50 AM ET
66 - Major Adverse Cardiovascular Events in Patients With IBD Taking Anti-TNF vs JAK Inhibitors: A Propensity Matched Cohort Analysis
57 - Monitoring Gaps and Treatment Disparities Among Adults With Chronic Hepatitis B Infection in the United States: Role of Treatment Eligibility Criteria
68 - Respiratory Syncytial Virus Vaccine is Associated With Better Outcomes in Inflammatory Bowel Disease Patients over 60 Years Old: A US Propensity-Matched Study
Location: Terrace Ballroom 2-3
Presenting Author: Osama Hamid, MD – University of Texas Southwestern Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
9:10 AM - 9:20 AM ET
59 - A Recent Epidemiologic Shift in Herbal and Dietary Supplement-Induced Liver Injury: Two Decades of Experience From the U.S. Drug-Induced Liver Injury Network
Location: Terrace Ballroom 1
Presenting Author: Dina Halegoua-DeMarzio, MD – Sidney Kimmel Medical College at Thomas Jefferson University
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
9:10 AM - 9:20 AM ET
69 - Real World Comparison of Effectiveness, Durability, and Safety of First-Line Advanced Therapies for Ulcerative Proctitis
70 - Efficacy and Safety of Upadacitinib Maintenance Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Two Year Results From the U-ENDURE Long-Term Extension Study
61 - Evaluating the Impact of Palliative Care Consultation on 30- and 90-Day Readmissions Among Patients With Decompensated Cirrhosis: A National Perspective
Location: Terrace Ballroom 1
Presenting Author: Aya Akhras, MD – HCA Florida Aventura Hospital and Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
9:30 AM - 9:40 AM ET
71 - Efficacy of Mirikizumab by Baseline Disease Location in Moderately to Severely Active Crohn’s Disease: Results of the Phase 3 VIVID-1 Study
Location: Terrace Ballroom 2-3
Presenting Author: Edward Barnes, MD, MPH, FACG – University of North Carolina at Chapel Hill School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
9:40 AM - 9:50 AM ET
62 - GLP-1RA and Safety of Gastrointestinal (GI) Endoscopic Procedures A Systematic Review and Meta-Analysis (Late-Breaking Abstract)
Location: Terrace Ballroom 1
Late Breaking Abstract Presenter: Violeta B. Popov, MD, PhD, FACG – NYU Langone Health NY VA Harbor Health System (Manhattan)
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 30th
9:40 AM - 9:50 AM ET
72 - Efficacy and Safety of Subcutaneous Guselkumab Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results Through Week 48 From the Phase 3 GRAVITI Study
63 - AIM65 as an Indicator of Rebleed and Mortality Risk in Patients Using Factor Xa Inhibitors Hospitalized for a Gastrointestinal (GI) Bleed (Late-Breaking Abstract)
73 - Week 48 Efficacy Of Guselkumab And Ustekinumab In Crohn’s Disease Based On Prior Response/Exposure To Biologic Therapy: Results From The GALAXI 2 and 3 Phase 3 Studies
64 - A Randomized, Double-Blind, Placebo Controlled Dose Ranging Study of Auxora in Patients with Acute Pancreatitis (AP) and Accompanying Systemic Inflammatory Response Syndrome (SIRS) - CARPO (NCT04681066) (Late-Breaking Abstract)
74 - TUSCANY-2: A Dose-Ranging Phase IIb Study Evaluating Efficacy and Safety of RO7790121, an Antibody Against Tumor Necrosis Factor-Like Ligand 1A (Anti-TL1A) in Adults With Moderately to Severely Active Ulcerative Colitis